JNCI Journal of the National Cancer Institute · 2013 · 22 citations · 15 references
MedicineOncologyPharmacologyBiochemical PharmacologyCancer PharmacologyMolecular OncologyCancer MetabolismOncology PharmacologyReactive Oxygen SpeciesAnticancer ActivityCell Viability AssaysOxidative Dna DamageOxidative Stress In CancerOxidative Stress InjuryReactive Oxygen Species GenerationReactive Oxygen Species InjuryRedox Metabolism In Cancer
BACKGROUND: Tumor cells present high levels of oxidative stress. Cancer therapeutics exploiting such biochemical changes by increasing reactive oxygen species (ROS) production or decreasing intracellular ROS scavengers could provide a powerful treatment strategy. METHODS: To test the effect of our compound, obtusaquinone (OBT), we used several cell viability assays on seven different glioblastoma (GBM) cell lines and primary cells and on 12 different cell lines representing various cancer types in culture as well as on subcutaneous (n = 7 mice per group) and two intracranial GBM (n = 6-8 mice per group) and breast cancer (n = 6 mice per group) tumor models in vivo. Immunoblotting, immunostaining, flow cytometry, and biochemical assays were used to investigate the OBT mechanism of action. Histopathological analysis (n = 2 mice per group) and blood chemistry (n = 2 mice per group) were used to test for any compound-related toxicity. Statistical tests were two-sided. RESULTS: OBT induced rapid increase in intracellular ROS levels, downregulation of cellular glutathione levels and increase in its oxidized form, and activation of cellular stress pathways and DNA damage, subsequently leading to apoptosis. Oxidative stress is believed to be the main mechanism through which this compounds targets cancer cells. OBT was well tolerated in mice, slowed tumor growth, and statistically prolonged survival in GBM tumor models. The ratio of median survival in U251 intracranial model in OBT vs control was 1.367 (95% confidence interval [CI] of ratio = 1.031 to 1.367, P = .008). Tumor growth inhibition was also observed in a mouse breast cancer model (average tumor volume per mouse, OBT vs control: 36.3 vs 200.4mm(3), difference = 164.1mm(3), 95% CI =72.6 to 255.6mm(3), P = .005). CONCLUSIONS: Given its properties and efficacy in cancer killing, our results suggest that OBT is a promising cancer therapeutic.
15
Identification of human brain tumour initiating cells
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke et al. · Nature · 2004 · 7.4K citations
Medicine, Cancer Biology, Oncology +11
Bert Vogelstein, David P. Lane, Arnold J. Levine · Nature · 2000 · 6.6K citations
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Production of large amounts of hydrogen peroxide by human tumor cells.
Ted P. Szatrowski, Carl Nathan · PubMed · 1991 · 2.5K citations
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Gentao Liu, Xiangpeng Yuan, Patrizia Tunici et al. · Molecular Cancer · 2006 · 1.8K citations · Full text
Medicine, Cell Biology, Oncology +17